246 related articles for article (PubMed ID: 25915847)
1. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
[TBL] [Abstract][Full Text] [Related]
2. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
3. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
[TBL] [Abstract][Full Text] [Related]
4. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.
Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A
Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194
[TBL] [Abstract][Full Text] [Related]
5. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
[TBL] [Abstract][Full Text] [Related]
6. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
[TBL] [Abstract][Full Text] [Related]
7. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
Haase G; Gavert N; Brabletz T; Ben-Ze'ev A
Oncogene; 2017 Mar; 36(11):1597-1606. PubMed ID: 27641335
[TBL] [Abstract][Full Text] [Related]
8. A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.
Saha A; Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008869
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
[TBL] [Abstract][Full Text] [Related]
10. The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis.
Haase G; Gavert N; Brabletz T; Ben-Ze'ev A
Cancers (Basel); 2016 May; 8(5):. PubMed ID: 27187476
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.
Gavert N; Ben-Shmuel A; Lemmon V; Brabletz T; Ben-Ze'ev A
J Cell Sci; 2010 Jun; 123(Pt 12):2135-43. PubMed ID: 20501702
[TBL] [Abstract][Full Text] [Related]
12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
Basu S; Cheriyamundath S; Gavert N; Brabletz T; Haase G; Ben-Ze'ev A
Oncotarget; 2019 Aug; 10(50):5217-5228. PubMed ID: 31497251
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
16. ISG15 induction is required during L1-mediated colon cancer progression and metastasis.
Cheriyamundath S; Basu S; Haase G; Doernberg H; Gavert N; Brabletz T; Ben-Ze'ev A
Oncotarget; 2019 Dec; 10(67):7122-7131. PubMed ID: 31903170
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin Target Genes in Colon Cancer Metastasis: The Special Case of L1CAM.
Cheriyamundath S; Ben-Ze'ev A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228199
[TBL] [Abstract][Full Text] [Related]
18. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
[TBL] [Abstract][Full Text] [Related]
19. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
Nik AM; Reyahi A; Pontén F; Carlsson P
Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
[TBL] [Abstract][Full Text] [Related]
20. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
